Helping the medical community easily access new radiolabeled therapeutic and diagnostic substances.
Our nuclear medicine equipment includes automated synthesizers, dose dispensing systems, their shielding and accessories. We also develop customized synthetic methods and instruments adapted to the evolving needs of the radiochemistry industry.
Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies.
In a nutshell: designer and manufacturer of radiopharma instruments, ISO 9001-certified company, medical device distributor, close to its customers and partners.
What makes us different: we consider our customers' performance as our own and we put everything in place to improve it.
Our strength: every aspect of our products: design, manufacturing, commercial service, quality and support is under our full control. Our great multidisciplinary team makes this possible.
Our final goal: enable patients to have access to a wide range of radiotracers in the safest and most timely manner.
We develop innovating equipment which enables safe manipulation and quick access to radiolabeled therapeutic and diagnostic substances.
Drug developers
Nuclear medicine departments
Drug manufacturers
Trasis will exhibit at the 30th Annual Congress of the European Association of Nuclear Medicine in Vienna.
Meet our experts on booth n°419 at the Austria Center Vienna on 21-25 October, 2017 !
For the sixth year, EY, in collaboration with BNP Paribas Fortis and l’Echo, has organised the ‘Promising Company of the Year’ competition for the 6th time in Wallonia.
This award is open to growing start-ups that have demonstrated exceptional capability in terms of innovation, entrepreneurship, strategy, global awareness and determination.
